Administration of therapeutic protein products may elicit some degree of immune response leading to development of anti-drug antibodies (ADAs) in treated subjects. Neutralizing antibodies (NAbs) are a subset of ADAs that affect the biological activity of the biologic drug product. https://qbd.creative-diagnosti....cs.com/applications/
Tycka om
Kommentar
Dela med sig
